ArticleTargeted oncology2023

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases.

Gordon Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.